Latest: Laxmi Dental Ltd Q1 FY27 (Apr–Jun 2026) results →This page is Q4 FY26 (Jan–Mar 2026).All Q4 FY26 results →
LD

Laxmi Dental Ltd

Q4 FY26Healthcare Equipment & Supplies

Laxmi Dental Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Price₹198
Market cap₹1.1K Cr
P/E31.9
Updated23 Aug 2026
Read4 min read

What the Q4 FY26 call signalled

1 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned

The short version

The company aims to grow at a similar trajectory as the past years; last two years saw 24% and 16% growth respectively, despite challenges (Page 11). Company aims to maintain or improve EBITDA margins around 18%-20% and gross margins of 75%-80% by FY '27 or FY '28.

From Laxmi Dental Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Moderate growth
  • The company aims to grow at a similar trajectory as the past years; last two years saw 24% and 16% growth respectively, despite challenges (Page 11).
  • Management is confident in achieving broad-based growth across all segments in the medium to long term (Page 4, Page 16).
  • Dental lab business (domestic and international) is expected to see meaningful scale-up over next 2-3 years (Page 9).
  • Export revenue (currently 33-34%) has tremendous potential alongside domestic; focus will be opportunity-driven (Page 11).
  • Scanner deployment strategy supports higher growth for scanner-equipped dentists, enhancing aligner and lab business volumes (Page 8).
  • Aligner business is growing, with Bizdent recovering and Vedia expected to grow further internationally (Page 8-9).

2 more points from Laxmi Dental Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Laxmi Dental Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Laxmi Dental plans to deploy CAPEX based on operational capabilities and revenue growth.
  • In FY '26, they executed CAPEX of around Rs. 18.4 crores.
  • The company has IPO proceeds of approximately Rs. 99 crores available for further capital expenditure.
  • CAPEX will be balanced and phased according to revenue growth and operational needs.
  • Focus remains on organic growth with eyes open for strategic deals if they benefit the company.

2 more points from Laxmi Dental Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Equipment & Supplies

Ranked on what management guided this quarter

Guidance-ranked
1OSEL Devices
Rev 1Mar 3
Rev 1Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Laxmi Dental Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Sameer Merchant mentioned being in an "active phase of registration" for international markets.
  • Business momentum is positive, with strong domestic and international growth, and digital penetration at 80%, targeting 90%.
  • Scanner deployment is ongoing, contributing to higher revenue growth from digital dentists.
  • Management remains confident about growth prospects but refrains from giving fixed timelines or detailed order book data due to regulatory uncertainties and market variables.

2 more points from Laxmi Dental Ltd's call on order book

Create a free account to keep reading this call

Laxmi Dental Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹74 Cr, net profit ₹10 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Equipment & Supplies this season

  • Nureca Ltd (Q4 FY26)

    Q4 FY26 Gross Merchandise Value (GMV): INR 49.7 Crore, 4% YoY growth (Q4 FY25: INR 48 Crore) . Key investor presentation takeaways from Nureca's Q4 FY26 investo

  • Vaidya Sane (Q4 FY26)

    170-180 crores driven by higher patient additions, increased hospital utilization, and franchise clinic growth. Key concall takeaways from Vaidya Sane Ayurved…

  • OSEL Devices (Q4 FY26)

    PAT growth was 45.7% in FY26; management is optimistic about sustaining or improving profitability and EPS in coming years. Key concall takeaways from OSEL…

  • Vasa Denticity (Q4 FY26)

    The company has a debt line of ₹15 crore available from financial partners. Key concall takeaways from Vasa Denticity Ltd's Q4 FY26 earnings call — and how it…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Laxmi Dental Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Laxmi Dental Ltd Q4 FY26 results?

The company aims to grow at a similar trajectory as the past years; last two years saw 24% and 16% growth respectively, despite challenges (Page 11). Company aims to maintain or improve EBITDA margins around 18%-20% and gross margins of 75%-80% by FY '27 or FY '28.

What is Laxmi Dental Ltd share price analysis?

Laxmi Dental Ltd currently shows a below-average growth signal. The stock trades at a P/E of 31.9 with a market cap of ₹1,110 Cr. Investors should review the full earnings analysis for detailed insights.

Is Laxmi Dental Ltd planning capital expenditure?

Laxmi Dental plans to deploy CAPEX based on operational capabilities and revenue growth. - In FY '26, they executed CAPEX of around Rs.

Keep Laxmi Dental Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.